Accuri and eBIOSCIENCE Partner to Offer Complete Flow Cytometry Solutions
News May 11, 2010
Accuri Cytometers, Inc. and eBioscience announced that they have entered into a worldwide co-marketing agreement.
The collaboration is designed to offer scientists a better and more comprehensive solution for their flow cytometry research needs, harnessing ease-of-use, performance capabilities and accessibility of the Accuri C6 Flow Cytometer® System with extensive line of high quality cytometer research reagents offered by eBioscience.
Explicitly designed for routine use by biomedical researchers in their own labs, Accuri’s full-featured bench-top cell analysis system provides capabilities similar to flow cytometers in a user-friendly format and at a fraction of the cost. eBioscience, which is among the largest suppliers of flow cytometry research reagents worldwide, offers a wide range of high quality flow cytometry research reagents optimized for a variety of applications.
Accuri designed the C6 system from the ground up with input from hundreds of researchers. Accuri's innovations, coupled with its components, resulted in a cytometer that is robust, compact, easy-to-use and affordable, at less than one-third the price of current flow cytometers and one-tenth the operating costs of the market leaders over five years of ownership, the companies say.
Further terms of the agreement were not disclosed.